November 2018

Column

Prognostication and Treatment of Diffuse Large B-cell Lymphoma

12/05/2018

Journal of Clinical Pathways is pleased to present a new section called “CME Corner,” which will highlight, when available, relevant continuing medical education (CME) opportunities deemed to be of use to readers....

...

12/05/2018

Journal of Clinical Pathways

Column

Editor's Page

Working Together: Novel Partnerships and Patient Perspectives

11/19/2018

Winston Wong , PharmD;

The internet has made global communication part of daily life in the United States—a few clicks on a computer or a phrase typed into a search engine can bring almost any type of knowledge to the user’s fingertips....

The...

11/19/2018

Journal of Clinical Pathways

Pharma Insights

Will Any Value Frameworks Gain Acceptance as an Informal Health Technology Assessment in the United States?

11/18/2018

Tricia Garland ;

Stephanie Kennedy , PhD;

Larry Blandford , PharmD;

Todd Edgar , PharmD, MS, SVP;

In recent years, several value frameworks, including the Institute for Clinical and Economic Review, have emerged to help payers assess the value of new drugs. These frameworks highlight efforts to adopt some type of...

In...

11/18/2018

Journal of Clinical Pathways

Business of Pathways

Engaging in Nontraditional Partnerships to Improve Population Health

11/18/2018

Silas Martin , MS;

Robert A. Bailey , MD;

Ira Klein , MD, MBA, FACP;

Population health, which encompasses the health outcomes of a specific group of individuals, has become an important concept in modern health care systems. Many public policy initiatives in recent years have included...

...

11/18/2018

Journal of Clinical Pathways

Clinical Pathways GPS

How the Proposed Elimination of Medicare Rebates Would Impact Clinical Pathways

11/18/2018

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

The Centers for Medicare & Medicaid Services (CMS) has published a range of new proposed and final rules regarding payment rates and policies affecting providers, payers, and patients. The Trump administration...

The...

11/18/2018

Journal of Clinical Pathways

Editorial

Charting a Path Forward for the Oncology Care Model

11/18/2018

Nicolas Ferreyros ;

The Oncology Care Model (OCM) is a federal health reform program that aims to change the way cancer care in America is delivered. Its goal? To provide high quality, well-coordinated cancer care to patients while...

The...

11/18/2018

Journal of Clinical Pathways

News

Conference Coverage

European Society for Medical Oncology 2018 Congress

11/19/2018

JCP Editors

The European Society for Medical Oncology (ESMO) is Europe’s leading professional organization for medical oncology education and information. With over 13,000 members representing oncology professionals from more...

The...

11/19/2018

Journal of Clinical Pathways

Conference Coverage

Academy of Managed Care Pharmacy Nexus 2018

11/18/2018

JCP Editors

The Academy of Managed Care Pharmacy (AMCP) is the leading professional organization for practitioners invested in the development and implementation of value-based care pathways within the managed care setting....

The...

11/18/2018

Journal of Clinical Pathways

Feature

Research Reports

Cancer Patient Perspectives on the Use of Clinical Pathways and Shared Decision-Making in Cancer Care

11/18/2018

Linda House , MSM, BSN, RN;

Elizabeth F. Franklin , MSW, LGSW, ACSW;

Shauna McManus , BS;

Helen M. Nichols , PhD, MSW;

Ellyn Charap , MS;

Joanne S. Buzaglo , PhD;

Abstract: The United States has one of the most expensive heath care systems in the world, and the costs of cancer care are rising faster than costs in other medical fields. Value-based care is being implemented in...

...

11/18/2018

Journal of Clinical Pathways

Perspectives

Lessons From Effective Value-Based Care Models in Hematopoietic Stem Cell Transplantation

11/16/2018

James Gajewski , MD, MACP;

Abstract: Patient-centered medical homes (PCMHs) have been designed to offer coordinated care delivery across the entire spectrum of care, aiming to provide optimal care for patients given their individual...

...

11/16/2018

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

November 2018

Column

News

Feature

Current Issue

Special Reports

Subscribe

Volume 4

Specialties

Events

Year Round Education

HMP Global Products